Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

media

228 POSTS

Exclusive articles:

NSDL IPO: National Securities Depository Ltd. Set for Market Debut

Overview of NSDL IPO The upcoming NSDL IPO (National Securities Depository Ltd. IPO) is drawing attention from investors as it prepares for its listing on...

Aura Minerals Eyes U.S. Growth With $210 Million IPO Amid Strategic Expansion

Aura Minerals, a Canada- and U.S.-based gold and copper producer with deep operational roots in Latin America, has officially launched a $210 million IPO...

MasonGlory Ltd (MSGY): New IPO from Hong Kong’s Wet Trade Contractor – In-Depth Analysis, Challenges, and Opportunities

Against the backdrop of volatile global capital markets in 2024–2025, MasonGlory Ltd (MSGY) is launching its IPO on Nasdaq Capital Market, pricing shares between...

Globa Terra Acquisition Corp (GTERU): Deep Dive into a New SPAC with Global Ambitions

In recent months, investor attention has increasingly turned toward new SPACs (Special Purpose Acquisition Companies)—blank-check firms that offer flexible, streamlined merger pathways for private...

Anthem Biosciences Limited IPO: What Investors Need to Know in 2025

Anthem Biosciences IPO is generating buzz in the Indian capital markets as one of the year’s most anticipated bookbuilding offerings. With an estimated size...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img